Smaller biotech companies are typically more science-minded and sometimes lose sight of the end commercialization goal. For large pharmaceutical companies however, reimbursement is front-of-mind when considering a new drug.
Small biotech companies need to consider:
• Due diligence
• Commercial analysis
• Risk vs return for a big pharma company